Jessica Jensen

Statistics

Publications

Citations

1.1K

H-Index

Active since

2017

Affiliations

Progenics Pharmaceuticals (United States)(Current)

Johns Hopkins University

Memorial Sloan Kettering Cancer Center

University of Michigan

Université Laval

Jessica Jensen is an author at Progenics Pharmaceuticals (United States) specializing in medicine, nuclear medicine, and positron emission tomography.

Publications per year

2017–2021

Publications

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Michael J. Morris, Steven P. Rowe, Michael A. Gorin et al. · Clinical Cancer Research · 2021 · 380 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup> F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe et al. · The Journal of Urology · 2021 · 372 citations · Full text

Medicine, Oncology, Radiology +17

Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

Daniel A. Pryma, Bennett B. Chin, Richard B. Noto et al. · Journal of Nuclear Medicine · 2018 · 283 citations · Full text

Medicine, Oncology, Pharmacology +8

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

Richard B. Noto, Daniel A. Pryma, Jessica Jensen et al. · The Journal of Clinical Endocrinology & Metabolism · 2017 · 65 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY

Steven P. Rowe, Michael A. Gorin, Kenneth J. Pienta et al. · 2019 · 19 citations

Medicine, Nuclear Medicine, Radiology +17

1–5 of 5